Equities analysts expect Medical Properties Trust, Inc. (NYSE:MPW) to announce sales of $187.42 million for the current fiscal quarter, Zacks reports. Eight analysts have provided estimates for Medical Properties Trust’s earnings, with the lowest sales estimate coming in at $173.61 million and the highest estimate coming in at $200.21 million. Medical Properties Trust reported sales of $204.96 million in the same quarter last year, which indicates a negative year-over-year growth rate of 8.6%. The business is scheduled to issue its next earnings report on Thursday, February 14th.
On average, analysts expect that Medical Properties Trust will report full year sales of $784.40 million for the current financial year, with estimates ranging from $687.59 million to $821.81 million. For the next year, analysts anticipate that the company will post sales of $802.01 million, with estimates ranging from $718.71 million to $850.16 million. Zacks’ sales calculations are a mean average based on a survey of sell-side research analysts that follow Medical Properties Trust.
Medical Properties Trust (NYSE:MPW) last issued its quarterly earnings data on Thursday, November 1st. The real estate investment trust reported $0.35 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.34 by $0.01. Medical Properties Trust had a net margin of 124.88% and a return on equity of 9.06%. The company had revenue of $197.00 million during the quarter, compared to the consensus estimate of $192.64 million. During the same quarter in the prior year, the firm earned $0.33 earnings per share. The firm’s revenue was up 11.6% compared to the same quarter last year.
Shares of MPW stock traded up $0.04 during trading hours on Friday, hitting $17.40. 2,327,899 shares of the company were exchanged, compared to its average volume of 3,155,891. The company has a quick ratio of 4.92, a current ratio of 4.92 and a debt-to-equity ratio of 0.90. Medical Properties Trust has a 52 week low of $11.82 and a 52 week high of $17.44. The company has a market capitalization of $6.30 billion, a price-to-earnings ratio of 12.89, a P/E/G ratio of 3.21 and a beta of 0.50.
The firm also recently announced a quarterly dividend, which will be paid on Thursday, January 10th. Investors of record on Thursday, December 13th will be issued a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a yield of 5.75%. The ex-dividend date of this dividend is Wednesday, December 12th. Medical Properties Trust’s payout ratio is 74.07%.
In other Medical Properties Trust news, CEO Edward K. Aldag, Jr. sold 43,065 shares of the stock in a transaction on Wednesday, November 28th. The shares were sold at an average price of $16.78, for a total value of $722,630.70. Following the completion of the sale, the chief executive officer now owns 1,873,541 shares in the company, valued at $31,438,017.98. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Michael G. Stewart sold 12,400 shares of the stock in a transaction on Friday, October 12th. The shares were sold at an average price of $14.13, for a total transaction of $175,212.00. Following the completion of the sale, the director now owns 231,039 shares of the company’s stock, valued at approximately $3,264,581.07. The disclosure for this sale can be found here. Company insiders own 0.83% of the company’s stock.
A number of hedge funds have recently made changes to their positions in MPW. FMR LLC lifted its stake in Medical Properties Trust by 96.7% in the third quarter. FMR LLC now owns 3,876,161 shares of the real estate investment trust’s stock valued at $57,793,000 after acquiring an additional 1,905,961 shares during the last quarter. LSV Asset Management lifted its stake in Medical Properties Trust by 13.9% in the second quarter. LSV Asset Management now owns 10,487,800 shares of the real estate investment trust’s stock valued at $147,248,000 after acquiring an additional 1,280,000 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. lifted its stake in Medical Properties Trust by 1,361.8% in the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 1,251,587 shares of the real estate investment trust’s stock valued at $18,661,000 after acquiring an additional 1,165,970 shares during the last quarter. Renaissance Technologies LLC acquired a new stake in Medical Properties Trust in the third quarter valued at $12,644,000. Finally, BlackRock Inc. lifted its stake in Medical Properties Trust by 2.1% in the third quarter. BlackRock Inc. now owns 41,840,443 shares of the real estate investment trust’s stock valued at $623,840,000 after acquiring an additional 846,940 shares during the last quarter. Hedge funds and other institutional investors own 76.59% of the company’s stock.
About Medical Properties Trust
Medical Properties Trust, Inc is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.